The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits

Virchows Archiv

Volumn 437, Issue 5, 2000, Pages 545-554

  Aragoncillo, Paloma ^a   Maeso, Rosaura ^b   Vázquez Pérez, Sandra ^b   Navarro Cid, Josefa ^b   Ruilope, Luis Miguel ^c   Díaz, Cristina ^d   Hernández, Gonzalo ^d   Lahera, Vicente ^b   Cachofeiro, Victoria ^b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b SCHOOL OF MEDICINE   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d Affinity Petcare   (Spain)

Author keywords

Dyslipidemia; Endothelial function; Statin; Ultrastructure; Vascular wall

Indexed keywords

ACETYLCHOLINE; ATORVASTATIN; CHOLESTEROL; COCONUT OIL; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; DRUG MECHANISM; DYSLIPIDEMIA; ENDOTHELIUM CELL; INTIMA; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; MALE; MICROSCOPY, ELECTRON; PYRROLES; RABBITS;

EID: 0033672879     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000278     Document Type: Article

References (45)

1. Electron spin resonance studies of fatty acid-induced alterations in membrane fluidity in cultured endothelial cells
2. Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet
3. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion
4. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: Antiatherogenic effects of HMG-CoA reductase inhibitor therapy
5. Change in endothelial cell morphology at arterial branch sites caused by a reduction of intramural stress
6. Effect of atherosclerosis on transmural convection and arterial ultrastructure. Implications for local intravascular drug delivery
7. Direct vascular effects of HMG-CoA reductase inhibitors
8. Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics
9. Hepatic and nonhepatic sterol synthesis and tissue distribution of a liver selective HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
10. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice
11. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium
12. Lovastatin maintains nitric-oxide but not EDHF-mediated endothelium-dependent relaxation in the hypercholesterolemic rabbit carotid artery
13. Sex and age as factors influencing the vascular reactivity in watanabe heritable hyperlipidaemic (WHHL) rabbits: A pharmacological and morphological study of the hepatic artery
14. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
15. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolemia
16. Direct effects of statins on the vascular wall
17. Increased thromboxane biosynthesis in type IIa hypercholesterolemia
18. Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effect of simvastatin treatment
19. T helper cell infiltration and foam cell proliferation are early events in the development of atherosclerosis in cholesterol-fed rabbits
20. Compensatory enlargement of human atherosclerotic coronary arteries
21. Early extracellular and cellular lipid deposits in aorta of cholesterol-fed rabbits
22. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
23. Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit
24. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors
25. The unstable atheroma
26. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361,662 men
27. Stabilization of atherosclerotic plaque during lipid lowering
28. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test
29. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets
30. The impact of atherosclerotic arterial remodeling on percentage of luminal stenosis varies widely within the arterial system. A postmortem study
31. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis
32. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits
33. The pathogenesis of atherosclerosis: A perpespective for the 1990s
34. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein
35. Myosin gene expression and cell phenotypes in vascular smooth muscle during development in experimental models and in vascular disease
36. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
37. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
38. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits
39. Proatherosclerotic events: Pathobiochemical changes occurring in the arterial wall before monocyte migration
40. Effect of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholestrolemia
41. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level
42. Comparison of statins in hypertriglyceridemia
43. Role of nitric oxide-related mechanisms in renal function in ageing rats
44. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease
45. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis